Your browser doesn't support javascript.
loading
How strong is the evidence to support statins repurposing for the treatment of cirrhosis?
Moctezuma-Velázquez, Carlos; G. Abraldes, Juan.
Affiliation
  • Moctezuma-Velázquez, Carlos; University of Alberta. Department of Gastroenterology. Liver Unit. Edmonton. Canada
  • G. Abraldes, Juan; University of Alberta. Department of Gastroenterology. Liver Unit. Edmonton. Canada
Rev. esp. enferm. dig ; Rev. esp. enferm. dig;115(3): 107-109, 2023.
Article in En | IBECS | ID: ibc-217232
Responsible library: ES1.1
Localization: ES15.1 - BNCS
Subject(s)
Search on Google
Add to My VHL
Print
XML

Collection: 06-national / ES Database: IBECS Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Evidence-Based Practice / Liver Cirrhosis Limits: Humans Language: En Journal: Rev. esp. enferm. dig Year: 2023 Document type: Article
Search on Google
Add to My VHL
Print
XML

Collection: 06-national / ES Database: IBECS Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Evidence-Based Practice / Liver Cirrhosis Limits: Humans Language: En Journal: Rev. esp. enferm. dig Year: 2023 Document type: Article